[1] 邱蔚六.口腔颌面外科理论与实践[M].北京:人民卫生出版社,2000:644-645. [2] Lin YW, Huang ST, Wu JC,et al. Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis[J].BMC Cancer,2019,19(1):1083. [3] Lin X, Khalid S, Qureshi MZ,et al.VEGF mediated signaling in oral cancer[J].Cell Mol Bio,2016 , 62(14):64-68. [4] Almangush A, Heikkinen I, Mkitie AA,et al. Prognostic biomarkers for oral tongue squamous cell carcinoma:a systematic review and meta-analysis[J]. Br J Cancer,2017,117(6):856-866. [5] 李晓光,王延秀,侯刚,等. 口腔鳞癌中血管内皮生长因子表达和微血管密度与预后关系的研究[J].中华口腔医学杂志,2003,38(1):78-78. [6] 段丽君,王欣,聂敏海.Survivin在口腔鳞状细胞癌中的表达和研究进展[J].泸州医学院学报,2012,35(5):538-540. [7] 王智明,管新明,魏巍,等.Survivin在舌鳞癌中的表达及其与血管内皮生长因子的相关性[J].口腔颌面外科杂志,2008,18(2):92-94. [8] 徐亚娟,金志威,张艳秋,等.Survivin蛋白在舌鳞癌中的表达及意义[J].中国实验诊断学,2012,16(11):2094-2095. [9] 王智明,刘芳,管新明,等.Survivin在舌鳞癌中的表达及意义[J].上海口腔医学,2007,16(2):157-160. [10] 解乃昌,李国威,王志亮,等.抗血管内皮生长因子抗体对实验性肝癌的生长抑制作用 [J].中国普外基础与临床杂志,2002,9(4):242-245. [11] 李晓光, 王延秀,周宝琴,等.VEGF-ASODN转染对舌癌Tca8113细胞VEGF表达及生长的抑制作用[J].上海口腔医学, 2009,18(5):509-514. [12] 李晓光,王延秀,高德安,等.VEGF反义寡核苷酸对舌鳞癌影响的实验研究[J].口腔颌面外科杂志,2009,19(6):395-399. [13] Li F,Brattain MG.Role of the Survivin gene in pathophysiology[J].Am J Pathol,2006,169(1):1-11. [14] Blanc-Brude OP,Mesri M,Wall NR,et al.Therapeutic targeting of the survivin pathway in cancer:initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis[J].Clin Cancer Res,2003,9(7):2683-2692. [15] 陈余清,李伟,周继红,等.survivin 抗肺癌细胞凋亡的分子机制[J].中华肿瘤杂志,2006,28(6):413-417. [16] Izant JG,Weintraub H. Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis[J].Cell,1984,36(4):1007-1015. [17] Crooke ST.Oligonucleotide analogs might be designed to bind to m-RNA [J].Anticancer Drug Des,1997,12(5):311-313. [18] Wu YF,Liang XJ,Liu YY,et al.Antisense oligonucleotide targeting survivin inhibits growth by inducing apoptosis in human osteosarcoma cells MG-63[J].Neoplasma,2010,57(6) : 501-506. [19] 李春艳,成小松,李曦.硫代修饰脂质体包裹反义VEGF寡核苷酸对肺癌血流的影响[J].中国肿瘤生物治疗杂志,2006,13(1):22-26. [20] 王学虎,傅仲学,谌伟,等. VEGF上调不同类型细胞 survivin 的表达[J].基础医学与临床,2009,29(12):1239-1243. [21] Wang L,Li X,Li Y,et al.Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features[J]. Ai Zheng,2005,24(7):823-826. [22] 姜乃德,张崇红,卜小琨.非小细胞肺癌组织 VEGF-A 和 survivin表达临床意义的研究[J].中华肿瘤防治杂志,2010,17(9):677-679. [23] 范海涛,王伟华,徐文翠,等.survivin 与 VEGF 在膀胱癌组织中的表达及 survivin ASODN 对膀胱癌细胞系的作用[J].中华肿瘤防治杂志,2007,14(7):541-543. [24] 0'Connor DS, Schechner JS,Adida C, et al. Control of apoptosis during angiogenesis by survivin expression in endothelial cells[J]. Am J Pathol,2000,156(2):393-398. [25] Mesri M,Morales-Ruiz M,Ackermann EJ,et al.Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting[J].Am J Patho1,2001,158(5):1757-1765. |